Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

NCT02980133 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

841

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone Propionate
DRUG: Fluticasone Propionate/Salmeterol
DRUG: Placebo MDPI

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.